4Arboix A, Rivas A, Garcia-Eroles L, et al. Cerebral infarction in diabetes : clinical pattern, stroke subtypes and predictors of in-hospital mortality [J]. Neurology,2005;5(9) :1186-71.
5Souto JC, Almasy L, Sofia JM,et al. Genome-wide linkage analysis of yon Willebrand factor plasma levels: results from the GAIT project [J]. Thromb Haemost ,2003 ;89 ( 3 ) :468-74.
4Hoogeveen EK,Kostense PJ,Jakobs C,et al.Hyperhomocysteinemia increases risk of death,especially in type 2 diabete:5-year follow-up of the Hoorn Study[J].Circulation,2000,101(13):1506-1511.
6Keman WN, lnzucchi SE, Vlscoli CM, et al. Pioglitazone improves insulin sensitivity among nondiabetic patients with a recent transient ischemic attack or ischemic stroke [ J ]. Stroke, 2003, 34 ( 6 ) : 1431 - 1436.
7Clocquet AR, Egan JM, Stoffers DA, et al. impaired insulin secretion and increased insulin sensitivity in familial maturity-onset diabetes of the young [ J ]. Diabetes ,2000,49 ( 11 ) : 1856 - 1864.
8Lawlor DA, Smith GD, Leon DA, et al. Secular trends in mortality by stroke subtype in the 20th century: A retrospective analysis[ J]. Lancet,2002,360(9348) :1818 - 1823.
9Lehto S, Niskanen L, Ronnemaa T,et al. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus [ J]. Stroke, 1998,29 (3) :635 - 639.
8Carey VJ, Bishop L, Laranjo N, et al. Contribution of high plasma triglycerides and low high-density lipoprotein cholesterol to residual risk of coronary heart disease after establishment of low-density lipoprotein cholesterol control [J]. Am J Cardiol , 2010, 106: 757-763.
9Okamura T, Kokubo Y, Watanabe M, et al. Triglycerides and non-high-density lipoprotein cholesterol and the incidence of cardiovascular dis- ease in an urban Japanese cohort: The Suita study [J]. Atherosclerosis, 2010, 209: 290-294.
